Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LINGO2 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | COL9A1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | RPA4 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | MBL2 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
mRNA | TUBA3D | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | SLC35E2 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | ZNF223 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | HBZ | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | PIWIL1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | POLI | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |